Catalent
CTLT
#1735
Rank
โ‚น1.035 T
Marketcap
โ‚น5,704
Share price
0.00%
Change (1 day)
20.50%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น568.81. In 2023 the company made an earnings per share (EPS) of -โ‚น611.04 a decrease over its 2022 EPS that were of โ‚น203.98.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-13.73%
2023-โ‚น611.04-399.56%
2022โ‚น203.98-30.58%
2021โ‚น293.8479.67%
2020โ‚น163.54114.12%
2019โ‚น76.38-15%
2018โ‚น89.8675.44%
2017โ‚น51.22-22.97%
2016โ‚น66.50-59.56%
2015โ‚น164.44282.05%
2014โ‚น43.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น29.65-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.39-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-โ‚น535.56-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-โ‚น132.99-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA